CUSIP: 23254L603
Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,064,450
-
Share change
-
-173,068
-
Total reported value
-
$1,211,253
-
Price per share
-
$0.59
-
Number of holders
-
23
-
Value change
-
-$100,417
-
Number of buys
-
5
-
Number of sells
-
7
Quarterly Holders Quick Answers
What is CUSIP 23254L603?
CUSIP 23254L603 identifies CYCC - CYCLACEL PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2023
-
Previous quarter:
Q1 2023
Recent filing periods for CUSIP 23254L603:
Institutional Holders of CYCLACEL PHARMACEUTICALS INC - COM (CYCC) as of Q2 2023
As of 30 Jun 2023,
CYCLACEL PHARMACEUTICALS INC - COM (CYCC) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,064,450 shares.
The largest 10 holders included
Schonfeld Strategic Advisors LLC, ACADIAN ASSET MANAGEMENT LLC, SPHERA FUNDS MANAGEMENT LTD., Point72 Asset Management, L.P., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, and Raymond James Financial Services Advisors, Inc..
This page lists
23
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.